Ark Biosciences is a clinical stage company focusing on innovative drug discovery and development, especially in the respiratory virus field, for world-wide markets. It is headquartered in the Zhangjiang Hi-tech Park of Shanghai, the heart of pharmaceutical innovation in China. As well as its own active discovery and development programs, Ark Biosciences has an active partner program, and licenses in drug assets for clinical development in the Asia-Pacific region. Ark Biosciences intends to become the driving force behind China's evolution into a global innovation center for drug discovery and development.
Ark Biosciences is a biopharmaceutical company dedicated to the discovery and development of innovative therapeutics to address unmet medical needs, especially in the area of respiratory viral infection and viral hepatitis, for both the global and Chinese markets.
We strive to build a science-driven biopharmaceutical company that aims to be a leader in antiviral drug discovery and development. To achieve this, we strive for scientific excellence and continuous innovation. We operate with razor-sharp focus and dedication, aiming to meet our deadlines in a cost efficient manner. We create a healthy and rewarding work environment for employees, and seek a superior rate of return for investors and partners
To ensure that we realize our vision to build a science-driven biotech company and achieve our goals, we adopt and uphold the following as our values: